middle.news
Mass General Brigham Joins Artrya’s SAPPHIRE Study to Advance Heart Disease Detection
9:47am on Wednesday 5th of November, 2025 AEDT
•
Healthcare
Read Story
Mass General Brigham Joins Artrya’s SAPPHIRE Study to Advance Heart Disease Detection
9:47am on Wednesday 5th of November, 2025 AEDT
Key Points
Mass General Brigham confirms in-principle participation in SAPPHIRE Study
Dr. Ron Blankstein appointed Principal Investigator of the study
SAPPHIRE Study to start early 2026 with 6–8 high-volume U.S. cardiology centers
Study evaluates Artrya’s Salix AI platform’s ability to detect coronary artery disease
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE